URGN

$41.40+2.10%website ↗⬇ financials (.py)

UroGen Pharma Ltd.

Market Cap

$2.0B

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.52

60mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

10.7

Price / TTM revenue

P/B

N/M

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Velocity Score

32.15x

Sell Rate (90d)

922.97/mo

Sell Baseline

71.34/mo

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-08	2026-09-09	Schoenberg Mark	Chief Medical Officer	Sale	871	$42.92	$37K	59.9K	View
2026-09-08	2026-09-09	Smith Jason Drew	General Counsel	Sale	1,519	$42.54	$65K	53.1K	View
2026-08-20	2026-08-24	Schoenberg Mark	Chief Medical Officer	Sale	60.7K	$47.05	$2.85M	59.1K	View
2026-07-09	2026-07-10	Schoenberg Mark	Chief Medical Officer	Sale	10.0K	$40.00	$400K	119.8K	View
2026-06-22	2026-06-24	Schoenberg Mark	Chief Medical Officer	Sale	10.0K	$35.01	$350K	129.8K	View

1–5 of 7

1 / 2

URGN

Signals

Factor Profile

Reporting Insiders

Recent News

UroGen Pharma Ltd. (URGN)

Factor Profile

Date	Insider	Type	Shares	Value
2026-09-08	Schoenberg Mark	S	871	$37,383.32
2026-09-08	Smith Jason Drew	S	1,519	$64,618.26
2026-08-20	Schoenberg Mark	S	60,677	$3M
2026-07-09	Schoenberg Mark	S	10,000	$400,000
2026-06-22	Schoenberg Mark	S	10,000	$350,100